Silver Book Fact

About 70% of the survival improvement in heart attack mortality resulted from changes in technology.

Cutler, David M. and Mark McClellan. Is Technological Change in Medicine Worth It?. Health Affairs. 2001; 20(5): 11-29. http://content.healthaffairs.org/content/20/5/11.full

Reference

Title
Is Technological Change in Medicine Worth It?
Publication
Health Affairs
Publication Date
2001
Authors
Cutler, David M. and Mark McClellan
Volume & Issue
Volume 20, Issue 5
Pages
11-29
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Glycoprotein inhibitors have been shown to reduce the risk of death, a second heart attack, or the need for revascularization by 48% to 52% in patients who have suffered a…  
  • Every additional dollar spent on the routine use of beta-blockers (versus under-use) in acute heart attack patients has produced health gains valued as high as $38.44.  
  • From 1979 to 2005, the total number of inpatient cardiovascular operations and procedures increased 484% to 6,989,000 annually.  
  • During the 1970s and 1980s, the gains associated with the prevention and treatment of cardiovascular disease totaled $31 trillion.  
  • Aspirin, beta-blockers, angiotensin-converting enzyme inhibitors, and statins, when taken in combination, have been estimated to reduce the relative risk of coronary heart disease mortality by 80%, compared with a placebo.